EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Zura Bio's enterprise value is $-71.36 Mil.
Zura Bio's Revenue for the trailing twelve months (TTM) ended in Mar. 2025 was $0.00 Mil. Therefore, Zura Bio's EV-to-Revenue for today is .
The historical rank and industry rank for Zura Bio's EV-to-Revenue or its related term are showing as below:
ZURA's EV-to-Revenue is not ranked *
in the Biotechnology industry.
Industry Median: 8.21 * Ranked among companies with meaningful EV-to-Revenue only.
As of today (2025-07-12), Zura Bio's stock price is $1.31.
Zura Bio's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2025 was $0.00. Therefore, Zura Bio's PS Ratio for today is .
Zura Bio EV-to-Revenue Historical Data
The historical data trend for Zura Bio's EV-to-Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Zura Bio's EV-to-Revenue
For the Biotechnology subindustry, Zura Bio's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Zura Bio's EV-to-Revenue Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Zura Bio's EV-to-Revenue distribution charts can be found below:
* The bar in red indicates where Zura Bio's EV-to-Revenue falls into.
Zura Bio's current Enterprise Value is $-71.36 Mil.
Zura Bio's Revenue for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Zura Bio's share price for today is $1.31.
Zura Bio's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Zura Bio EV-to-Revenue Related Terms
Thank you for viewing the detailed overview of Zura Bio's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
Zura Bio Ltd is a clinical-stage, multi-asset immunology company developing novel dual-pathway antibodies for autoimmune and inflammatory diseases. It is developing three assets which have completed Phase I/Ib studies and are Phase II ready. It is developing a portfolio of therapeutic indications for tibulizumab and torudokimab with a goal of demonstrating their efficacy, safety, and dosing convenience in autoimmune and inflammatory diseases.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
ZURA has been successfully added to your 